The episode was, the New York Times proclaimed, "a morality tale for our times." The excitement around GLP-1s feels eerily similar to the fen-phen craze, says Osborn
doi: 10.1038/s42255-024-01061-4 40 KillionEAChenMFalseyJRSivitsGHagerTAtanganLet al
Certified Compliance: Adherence to multiple standards including GMP, HACCP, QS, ISO, Halal, and more
Jacobson S, Margolese N, Margolese HC
Zambrowicz B, Ogbaa I, Frazier K, Banks P, Turnage A, Freiman J, Boehm KA, Ruff D, Powell D, Sands A
[1] [8] Phase 2 trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated substantial reductions in body weight with retatrutide, and Phase 3 trials are currently registered and under way (ClinicalTrials.gov)